Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating sorafenib tosylate after liver transplant for hepatocellular carcinoma and related liver cancers has compl…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer [Phase 2]
Phase II open-label study of BMS-582664 in locally advanced or metastatic hepatocellular carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update for MB07133 in unresectable hepatocellular carcinoma is reported, with safety and effect/tolerance considerati…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
A multi-phase clinical trial evaluating MB07133 plus sintilimab in hepatocellular carcinoma to assess safety and efficacy; current status is…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation [Phase 3]
A Phase 3 study evaluating atezolizumab plus bevacizumab versus active surveillance as adjuvant therapy in hepatocellular carcinoma at high …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation [Phase 3]
Phase 3 trial comparing atezolizumab plus bevacizumab to active surveillance as adjuvant therapy in high-risk hepatocellular carcinoma after…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC [Phase 4]
A Phase 4 trial assessing safety and efficacy of lenvatinib as first-line treatment in unresectable hepatocellular carcinoma has been comple…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma [NA]
Pilot study evaluating individualized adaptive radiation therapy for hepatocellular carcinoma has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer [Phase 2]
Phase 2 trial of BBI503 in adults with advanced hepatobiliary cancer (hepatocellular carcinoma and cholangiocarcinoma) has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of H3B-6527 in advanced hepatocellular carcinoma; trial completed wit…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer [NA]
Trial results for TheraSphere in patients with unresectable hepatocellular carcinoma have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE [Phase 4]
Phase 4 clinical trial evaluating the accuracy of contrast-enhanced ultrasound for hepatocellular carcinoma after transarterial chemoemboliz…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Y90 Radiation Segmentectomy vs SBRT for HCC [NA]
A terminated clinical trial comparing Y90 radiation segmentectomy versus SBRT for hepatocellular carcinoma has posted results in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC [Phase 4]
Phase 4 trial update investigating tislelizumab combined with TACE and lenvatinib as neoadjuvant therapy for resectable hepatocellular carci…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection [Phase 3]
Phase 3 clinical trial evaluating sintilimab plus lenvatinib as adjuvant therapy after surgical resection in hepatocellular carcinoma with p…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC [Phase 2, Phase 3]
A neoadjuvant trial combining transarterial chemoembolization/hemorrheology-assisted interventional therapy with lenvatinib and sintilimab i…
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC [Phase 2]
A Phase 2 clinical trial evaluating tislelizumab plus a tyrosine kinase inhibitor as adjuvant therapy versus active surveillance in hepatoce…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors [Phase 2]
Phase 2 trial update evaluating high-dose vitamin C with metformin for malignant tumors including hepatocellular and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Contrast-enhanced Ultrasound Evaluation of Chemoembolization [Phase 3]
This Phase 3 clinical trial update notes completion and results posting for using contrast-enhanced ultrasound to evaluate chemoembolization…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of sintilimab and bevacizumab with radiotherapy for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [Phase 1, Phase 2]
Clinical trial update evaluating SBRT with Cardonilizumab and Lenvastinib for unresectable hepatocellular carcinoma with portal vein tumor t…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC [Phase 2]
Phase 2 trial investigating avatrombopag for thrombocytopenia in hepatocellular carcinoma patients planned for transarterial chemoembolizati…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification [Phase 2]
Phase 2 clinical trial exploring hepatic arterial infusion combined with apatinib and camrelizumab for C-staged hepatocellular carcinoma (BC…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study of PTS100 in Primary HCC Patients [Phase 2]
Phase 2 clinical trial update for PTS100 in hepatocellular carcinoma (primary liver cancer).
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors [Phase 2]
Phase 2 clinical trial evaluating anlotinib in combination with TQB2450 for advanced hepatocellular carcinoma after prior immune checkpoint …